Figures & data
Figure 2 Schematic drawing of the parallel-plate system. The stent coated by endothelial cells was mounted in the parallel plate flow chamber. The hydrostatic pressure head established between the two reservoirs provided a constant volume flow rate through the flow chamber.
![Figure 2 Schematic drawing of the parallel-plate system. The stent coated by endothelial cells was mounted in the parallel plate flow chamber. The hydrostatic pressure head established between the two reservoirs provided a constant volume flow rate through the flow chamber.](/cms/asset/a6d671c9-a3bd-4450-b16d-932133623201/ianb19_a_142811_f0002_b.gif)
Table 1. Effect of different concentrations of substrates on adhesive forces of HUVECs
Figure 3 Adhesive forces of the HUVEC on the surface of the stents coated with different concentration of the stents coated with different concentrations of PLL and/or FN. A: VEC (Control); B: VEC + 1 µg/ml PLL; C: VEC + 2 µg/ml PLL; D: VEC + 5 µg/mlPLL; E: VEC + 2 µg/ml PLL + 1 µg/ml FN; F: VEC + 2 µg/ml PLL + 2 µg/ml FN; G: VEC + 2 µg/ml PLL + 5 µg/ml FN.
![Figure 3 Adhesive forces of the HUVEC on the surface of the stents coated with different concentration of the stents coated with different concentrations of PLL and/or FN. A: VEC (Control); B: VEC + 1 µg/ml PLL; C: VEC + 2 µg/ml PLL; D: VEC + 5 µg/mlPLL; E: VEC + 2 µg/ml PLL + 1 µg/ml FN; F: VEC + 2 µg/ml PLL + 2 µg/ml FN; G: VEC + 2 µg/ml PLL + 5 µg/ml FN.](/cms/asset/88af243c-0963-4436-91f4-f516f6b4f0ea/ianb19_a_142811_f0003_b.gif)
Figure 4 Endothelial cells grown on the surface of the intravascular stents exposed to the perfusion solution.
![Figure 4 Endothelial cells grown on the surface of the intravascular stents exposed to the perfusion solution.](/cms/asset/6e65b6f9-adb4-4696-ab9f-28c6ae2e3b23/ianb19_a_142811_f0004_b.gif)
Figure 5 Endothelial cells grown on the surface of the intravascular stents coated by PBS, at the fifth day.
![Figure 5 Endothelial cells grown on the surface of the intravascular stents coated by PBS, at the fifth day.](/cms/asset/9b9b4ba2-d08a-4f2e-83fd-257e444310f1/ianb19_a_142811_f0005_b.gif)
Figure 6 Endothelial cells grown on the surface of the intravascular stents coated by fobronectin (20 mg/ml) at the fifth day.
![Figure 6 Endothelial cells grown on the surface of the intravascular stents coated by fobronectin (20 mg/ml) at the fifth day.](/cms/asset/3cd63735-6369-45e8-8459-ae3760578380/ianb19_a_142811_f0006_b.gif)
Figure 7 Endothelial cells grown on the surface of the intravascular stents coated by the Poly-l-Lysine at the fifth day.
![Figure 7 Endothelial cells grown on the surface of the intravascular stents coated by the Poly-l-Lysine at the fifth day.](/cms/asset/f9bf5728-de7a-4b1a-a653-fffecffaeec7/ianb19_a_142811_f0007_b.gif)